Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Incidence, Natural History and Outcomes of Transient and Persistent Antiphospholipid Antibodies in Children and Young Adults with Provoked Venous Thromboembolism: Analysis of the Kids-DOTT Trial

Marisol Betensky, MDMPH, Anh Thy Nguyen, MSPH, Cristina Tarango, MD, Anupam R Verma, MD, Rukhmi Bhat, MDMS, Nicole Kucine, MD, Charles Nakar, MD, Gary Woods, MD, Frances L Hamblin, MSHS, RN, Ernest Amankwah, PhD, Neil A Goldenberg, MD PhD

Blood (2019) 134 (Supplement_1): 636.

https://doi.org/10.1182/blood-2019-131438

Published: 2019

Journal Articles

Using Current Clinical Markers to Define High Risk Smoldering Multiple Myeloma: Agree to Disagree

Elizabeth Hill, MD, Neha Korde, MD, Sham Mailankody, MBBS, Candis Morrison, CNP, PhD, Alexander Dew, DO, Jennifer Hsu Albert, RN, Katherine Graap, RN, Francesco Maura, MD, Ola Landgren, MD PhD, Dickran Kazandjian, MD

Blood (2019) 134 (Supplement_1): 1794.

https://doi.org/10.1182/blood-2019-126952

Published: 2019

Journal Articles

Assessment of a Multi-Cytokine Profile By a Novel Biochip-Based Assay Reveals Unique Correlation Patterns with Immune Reconstitution after Cord Blood Transplantation in Adults

Theodoros Karantanos, MD, Haesook T Kim, PhD, Lequn Li, MD PhD, Corey Cutler, MD MPH, FRCPC, Joseph H. Antin, MD, Karen Ballen, MD, Jerome Ritz, MD, Ioannis Politikos, MD, Vassiliki A Boussiotis, MD PhD

Blood (2017) 130 (Supplement 1): 1980.

https://doi.org/10.1182/blood.V130.Suppl_1.1980.1980

Published: 2017

Journal Articles

Dynamic BH3 Profiling to Assess the Effects of Novel Agents on Anti-Apoptotic Protein Dependence of CLL Cells

Rebecca Valentin, MD, Jing Deng, PhD, Elisa Ten Hacken, PhD, Timothy Z. Lehmberg, BA, Silvia Buonamici, PhD, Donna S. Neuberg, ScD, Catherine J. Wu, MD, Anthony Letai, MD PhD, Matthew S. Davids, MD MMSc

Blood (2017) 130 (Supplement 1): 4289.

https://doi.org/10.1182/blood.V130.Suppl_1.4289.4289

Published: 2017

Journal Articles

Maintenance Treatment with Lenalidomide for Multiple Myeloma Increases the Proportion of MRD Negative (Flow-/PET-CT-) Patients

Rafael Alonso Fernández, María Teresa Cedena, Rafael Rios, Javier Lopez Jimenez, Alejandro Sanz, Fernando Martín, Antonio Valeri, PhD, Juan Jose Lahuerta, Joaquin Martínez-López

Blood (2017) 130 (Supplement 1): 3098.

https://doi.org/10.1182/blood.V130.Suppl_1.3098.3098

Published: 2017

Journal Articles

Abnormal Increase in a Distinct Subset of Nestin-Expressing Cells in the Bone Marrow of Myelodysplastic Syndromes

Luan Cao-Sy, MS, Naoshi Obara, MD PhD, Tatsuhiro Sakamoto, MD, Takayasu Kato, MD PhD, Hidekazu Nishikii, MD, PhD, Mamiko Sakata-Yanagimoto, MD PhD, Shigeru Chiba, MD, PhD

Blood (2016) 128 (22): 3887.

https://doi.org/10.1182/blood.V128.22.3887.3887

Published: 2016

Journal Articles

Ibrutinib Therapy Increases BCL-2 Dependence and Enhances Sensitivity to Venetoclax in CLL

Jing Deng, Elif Isik, Stacey M. Fernandes, Jennifer R. Brown, MD PhD, Anthony Letai, MD PhD, Matthew S. Davids, MD

Blood (2015) 126 (23): 490.

https://doi.org/10.1182/blood.V126.23.490.490

Published: 2015

Journal Articles

Novel Multi-Target Immunosuppressive Approach for Treatment of Severe Aplastic Anemia

Kyle Blaine Russell, Brandon P Theall, Lisandra Hernandez, Hannah M Wavering, Vesna Jurecic, Samita Andreansky, PhD, Robert B. Levy, PhD, Roland Jurecic, PhD

Blood (2015) 126 (23): 3611.

https://doi.org/10.1182/blood.V126.23.3611.3611

Published: 2015

Journal Articles

Predictors of Early Death in Childhood Acute Promyelocytic Leukemia: Results of an International Retrospective Study

Oussama Abla, MD, Raul C. Ribeiro, MD, Anna Maria Testi, MD, Pau Montesinos Fernández, MD, Ursula Creutzig, MD, Lillian Sung, MD PhD, Giancarlo Di Giuseppe, BSc, Derek Stephens, MSc, Henrik Hasle, MD PhD, Gertjan J.L. Kaspers, MD PhD, Luciano Dalla-Pozza, MB BS FRACP, Alvaro Lassaletta, MD, Martin S. Tallman, MD, Franco Locatelli, MD, Dirk Reinhardt, MD, Johann Hitzler, MD FRCP (C), FAAP, Miguel A. Sanz, MD PhD

Blood (2015) 126 (23): 172.

https://doi.org/10.1182/blood.V126.23.172.172

Published: 2015

Journal Articles

Novel Immunosuppressive Approach Attenuates Severe Aplastic Anemia in Mouse Lymphocyte Infusion AA Models

Jessica Lorente, Divya Kannegenti, Brandon Theall, Lisandra Hernandez, Esha Vallabhaneni, Vesna Jurecic, Vineet Gupta, PhD, Becky Adkins, PhD, Roland Jurecic, PhD

Blood (2014) 124 (21): 2942.

https://doi.org/10.1182/blood.V124.21.2942.2942

Published: 2014

Journal Articles

Cost-Effectiveness Of Antithrombin Repletion In Adult Patients With Acute Lymphoblastic Leukemia (ALL) Treated With Asparaginase-Containing Combination Chemotherapy; A Single Center Experience

Kristen B. McCullough, PharmD, Jason N. Barreto, PharmD, Candy S Peskey, PharmD, Dennis A. Gastineau, MD, Michelle Elliott, MD, Naseema Gangat, MBBS, Mrinal M Patnaik, MBBS, Mark R. Litzow, MD, William J Hogan, MD

Blood (2013) 122 (21): 1732.

https://doi.org/10.1182/blood.V122.21.1732.1732

Published: 2013

Journal Articles

CD45-CD34+ Endothelial Progenitor Cells (EPCs) from Human Adipose Tissue Promote Tumor Growth and Metastases

Patrizia Mancuso, Ines Martin Padura, Giuliana Gregato, Paola Marighetti, Angelica Calleri, Chiara Corsini, Giancarlo Pruneri, Visnu Lohsiriwat, Jean Yves Petit, Francesco Bertolini

Blood (2011) 118 (21): 2208.

https://doi.org/10.1182/blood.V118.21.2208.2208

Published: 2011

Journal Articles

Quantitative Analysis of VWF Multimer Structure: Discrimination Between VWD Subtypes

Sandra L Haberichter, PhD, Paula M Jacobi, BA, Veronica H Flood, MD, Pamela A. Christopherson, Joan Cox Gill, MD, Daniel B. Bellissimo, PhD, Kenneth D Friedman, MD, The Zimmerman Program Investigators

Blood (2011) 118 (21): 1215.

https://doi.org/10.1182/blood.V118.21.1215.1215

Published: 2011

Journal Articles

Hematopoietic Chimerism LEVELS ARE RELATED to RELAPSE and GRAFT VERSUS Host DISEASE IN REDUCED INTENSITY Allogeneic STEM CELL Transplantion

Alejandro Contento-Gonzalo, Sandra Diaz-Gallardo, Maria Rosario Prieto-Bonilla, Maria Magdalena Alcala-Peña, Jiri Pavlu, Manuel Barrios, Antonio Jimenez-Velazco, Ana Isabel Heiniger Mazo

Blood (2010) 116 (21): 4702.

https://doi.org/10.1182/blood.V116.21.4702.4702

Published: 2010

Journal Articles

Clinical Significance of Lupus Anticoagulant and Anti-Beta 2 Glycoprotein I Antibodies in a Pediatric Cohort.

Rebecca P. Cook, MD, Marisa Marques, MD, Robert Oster, Ph.D.

Blood (2009) 114 (22): 3989.

https://doi.org/10.1182/blood.V114.22.3989.3989

Published: 2009

Journal Articles

Pathophysiology of Anti-PL Syndrome in Thrombosis.

Jacob H. Rand, MD

Blood (2009) 114 (22): SCI-45.

https://doi.org/10.1182/blood.V114.22.SCI-45.SCI-45

Published: 2009

Journal Articles

The Nuclear Orphan Receptors NR4A1 and NR4A3 as Putative Tumour Suppressor Genes in Aggressive Non-Hodgkin's Lymphomas.

Alexander JA Deutsch, Christine Beham-Schmid, Werner Linkesch, MD, Peter Neumeister, MD

Blood (2009) 114 (22): 2967.

https://doi.org/10.1182/blood.V114.22.2967.2967

Published: 2009

Journal Articles

Risk-adapted treatment of acute promyelocytic leukemia with all- trans retinoic acid and anthracycline monochemotherapy: long-term outcome of the LPA 99 multicenter study by the PETHEMA Group

Blood (2008) 112 (8): 3130–3134.

https://doi.org/10.1182/blood-2008-05-159632

Published: 2008

Journal Articles

Making business out of patients?

Pablo Menendez

Blood (2008) 112 (4): 1543.

https://doi.org/10.1182/blood-2008-05-154807

Published: 2008

Journal Articles

Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin

Blood (2008) 111 (7): 3395–3402.

https://doi.org/10.1182/blood-2007-07-100669

Published: 2008

NARROW

Incidence, Natural History and Outcomes of Transient and Persistent Antiphospholipid Antibodies in Children and Young Adults with Provoked Venous Thromboembolism: Analysis of the Kids-DOTT Trial

Using Current Clinical Markers to Define High Risk Smoldering Multiple Myeloma: Agree to Disagree

Assessment of a Multi-Cytokine Profile By a Novel Biochip-Based Assay Reveals Unique Correlation Patterns with Immune Reconstitution after Cord Blood Transplantation in Adults

Dynamic BH3 Profiling to Assess the Effects of Novel Agents on Anti-Apoptotic Protein Dependence of CLL Cells

Maintenance Treatment with Lenalidomide for Multiple Myeloma Increases the Proportion of MRD Negative (Flow-/PET-CT-) Patients

Abnormal Increase in a Distinct Subset of Nestin-Expressing Cells in the Bone Marrow of Myelodysplastic Syndromes

Ibrutinib Therapy Increases BCL-2 Dependence and Enhances Sensitivity to Venetoclax in CLL

Novel Multi-Target Immunosuppressive Approach for Treatment of Severe Aplastic Anemia

Predictors of Early Death in Childhood Acute Promyelocytic Leukemia: Results of an International Retrospective Study

Novel Immunosuppressive Approach Attenuates Severe Aplastic Anemia in Mouse Lymphocyte Infusion AA Models

Cost-Effectiveness Of Antithrombin Repletion In Adult Patients With Acute Lymphoblastic Leukemia (ALL) Treated With Asparaginase-Containing Combination Chemotherapy; A Single Center Experience

CD45-CD34+ Endothelial Progenitor Cells (EPCs) from Human Adipose Tissue Promote Tumor Growth and Metastases

Quantitative Analysis of VWF Multimer Structure: Discrimination Between VWD Subtypes

Hematopoietic Chimerism LEVELS ARE RELATED to RELAPSE and GRAFT VERSUS Host DISEASE IN REDUCED INTENSITY Allogeneic STEM CELL Transplantion

Clinical Significance of Lupus Anticoagulant and Anti-Beta 2 Glycoprotein I Antibodies in a Pediatric Cohort.

Pathophysiology of Anti-PL Syndrome in Thrombosis.

The Nuclear Orphan Receptors NR4A1 and NR4A3 as Putative Tumour Suppressor Genes in Aggressive Non-Hodgkin's Lymphomas.

Risk-adapted treatment of acute promyelocytic leukemia with all- trans retinoic acid and anthracycline monochemotherapy: long-term outcome of the LPA 99 multicenter study by the PETHEMA Group

Making business out of patients?

Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only